Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Quinine sulfate 125mg/5ml oral liquid
0504010Y0AABABA
|
Quinine sulfate | Quinine sulfate | Infections | No data available |
|
Quinine sulfate 150mg/5ml oral suspension
0504010Y0AAA5A5
|
Quinine sulfate | Quinine sulfate | Infections | No data available |
|
Quinine sulfate 250mg/5ml oral liquid
0504010Y0AAA7A7
|
Quinine sulfate | Quinine sulfate | Infections | No data available |
|
Quinine sulfate 25mg/5ml oral liquid
0504010Y0AABBBB
|
Quinine sulfate | Quinine sulfate | Infections | No data available |
|
Quinine sulfate 50mg/5ml oral liquid
0504010Y0AAA4A4
|
Quinine sulfate | Quinine sulfate | Infections | No data available |
|
Quinine sulfate 75mg/5ml oral liquid
0504010Y0AAA3A3
|
Quinine sulfate | Quinine sulfate | Infections | No data available |
|
Quinocort cream
1304000V0CEABCE
|
Quinocort | Hydrocortisone | Skin | No data available |
|
Quinoderm 5 cream
1306010C0BQACAU
|
Quinoderm | Benzoyl peroxide | Skin | No data available |
|
Quinsair 240mg nebuliser solution ampoules
0501120X0BDAAAF
|
Quinsair | Levofloxacin | Infections | No data available |
|
Quinupristin 150mg / Dalfopristin 350mg inf vials
0501070V0AAAAAA
|
Quinupristin/dalfopristin | Quinupristin/dalfopristin | Infections | No data available |
|
Quizartinib 17.7mg tablets
0801050CTAAAAAA
|
Quizartinib | Quizartinib | Malignant Disease and Immunosuppression | No data available |
|
Quizartinib 26.5mg tablets
0801050CTAAABAB
|
Quizartinib | Quizartinib | Malignant Disease and Immunosuppression | No data available |
|
QV 10% wash
130201100BBAYAL
|
Proprietary compound preparation BNF 1302011 | Emollient bath and shower preparations | Skin | No data available |
|
Rabies immunoglobulin human 500unit inj vials
1405020D0AAABAB
|
Rabies immunoglobulin | Rabies immunoglobulin | Immunological Products and Vaccines | No data available |
|
Rabies vacc inj 0.5ml vials
1404000N0AAADAD
|
Rabies vaccine | Rabies | Immunological Products and Vaccines | No data available |
|
Rabies vacc pdr & solv for soln inj 1ml vials
1404000N0AAABAB
|
Rabies vaccine | Rabies | Immunological Products and Vaccines | No data available |
|
Racecadotril 100mg capsules
0104030A0AAACAC
|
Racecadotril | Racecadotril | Gastro-Intestinal System | No data available |
|
Racecadotril 10mg granules for oral suspension sachets
0104030A0AAAAAA
|
Racecadotril | Racecadotril | Gastro-Intestinal System | No data available |
|
Racecadotril 30mg granules for oral suspension sachets
0104030A0AAABAB
|
Racecadotril | Racecadotril | Gastro-Intestinal System | No data available |
|
Racemic camphor 0.5% / Chloroxylenol 0.25% cream
131005000AAAYAY
|
Generic compound preparation BNF 1310050 | Other minor cut and abrasion preparations | Skin | No data available |
|
Raciran 150 tablets
0103010T0BEAAAA
|
Raciran | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Raciran 300 tablets
0103010T0BEABAC
|
Raciran | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Radian B Ibuprofen Massage stick
1003020P0BHABAC
|
Radian-B (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Radian B Muscle lotion
1003020N0BFAEAS
|
Radian-B (Methyl salicylate) | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Radian B Muscle rub
1003020N0BFACA0
|
Radian-B (Methyl salicylate) | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.